Ads
related to: glaxosmithkline pharmaceuticals- Dosing & Administration
Get Important Administration And
Storage Information For AREXVY.
- Clinical Information
Take a Deeper Dive Into Clinical
Study Info For AREXVY & Learn More.
- Important Safety Info
View The Full Safety Profile
And Learn About Adverse Reactions.
- HCP Resources
Watch Informational Videos Created
For Healthcare Professionals.
- Coverage Tool
Utilize A Coverage Tool For AREXVY
On The Official HCP Site.
- Retail Pharmacy Leaders
Make A Stocking Decision And
Find Options That Meet Your Needs.
- Dosing & Administration
Search results
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 12 hours agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
The Lash Group Notifies Consumers of Massive Data Breach Leaking Their Sensitive Medical Information...
JD Supra· 4 days agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information, which includes their first names, last names, dates ...
Goldman Sachs neutral on GlaxoSmithKline stock By Investing.com
Investing.com· 2 days agoThe firm highlighted GlaxoSmithKline's transition from a conglomerate to a company focused on...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar· 4 days agoAlmost a dozen pharmaceutical companies, including several major players, have lost sensitive...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC NEWS· 1 hour agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
Major drug companies caught up in Cencora data loss
The Register· 5 days agoMore than a dozen big pharmaceutical suppliers have begun notifying individuals that their data was stolen when US drug wholesaler Cencora was breached...
Novartis sues Maryland over law prohibiting restrictions on 340B drugs
Becker’s Hospital Review· 16 hours ago"Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."
Suzlon Competitor Crashes 10% To Become Worst Nifty 500 Performer On Tuesday
Benzinga· 3 days agoThe slump comes after a block deal involving a 5% stake in the company worth over ₹400 crore was...
Johnson & Johnson Data Breach Reported; Possibly Connected to Major Lash Group Data Breach | JD...
JD Supra· 3 days agoThe breach affected those registered with the Johnson & Johnson Patient Assistance Foundation, Inc., which is a sign the breach may be related to the much larger Lash Group data breach that’ ...
Expert Perspectives on Biggest Court Cases
Law.com· 11 hours agoLast week, after three weeks of trial and four hours of deliberations, a jury in Cook County Circuit Court rejected an Illinois woman’s claim that the...
